Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT05436223 · UNKNOWN
Trial details
- NCT number
- NCT05436223
- Sponsor
- Hrain Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2024-08-09
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.